Great West Life Assurance CO Eagle Pharmaceuticals, Inc. Transaction History

Great West Life Assurance CO

$57.4 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$17.74 - $31.87 $108,497 - $194,916	-6,116 Reduced 49.66%	6,200 $121,000
Q1 2023 May 12, 2023	BUY	$25.06 - $34.09 $28,844 - $39,237	1,151 Added 10.31%	12,316 $349,000
Q3 2022 Nov 01, 2022	BUY	$26.42 - $47.12 $3,381 - $6,031	128 Added 1.16%	11,165 $295,000
Q2 2022 Aug 12, 2022	BUY	$41.26 - $51.35 $455,386 - $566,749	11,037 New	11,037 $490,000
Q2 2022 Aug 09, 2022	SELL	$41.26 - $51.35 $420,026 - $522,743	-10,180 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$44.58 - $52.6 $30,581 - $36,083	686 Added 7.23%	10,180 $517,000
Q4 2021 Feb 14, 2022	SELL	$45.82 - $56.9 $6,735 - $8,364	-147 Reduced 1.52%	9,494 $484,000
Q1 2021 May 17, 2021	SELL	$40.32 - $50.97 $76,970 - $97,301	-1,909 Reduced 16.53%	9,641 $402,000
Q4 2020 Feb 16, 2021	SELL	$41.72 - $51.34 $27,118 - $33,371	-650 Reduced 5.33%	11,550 $538,000
Q3 2020 Nov 17, 2020	BUY	$37.02 - $51.28 $451,644 - $625,616	12,200 New	12,200 $518,000
Q3 2020 Nov 13, 2020	SELL	$37.02 - $51.28 $468,710 - $649,256	-12,661 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$43.24 - $55.02 $43,845 - $55,790	-1,014 Reduced 7.41%	12,661 $608,000
Q1 2020 May 14, 2020	BUY	$34.37 - $60.07 $34,954 - $61,091	1,017 Added 8.03%	13,675 $629,000
Q4 2019 Feb 11, 2020	BUY	$54.32 - $64.31 $687,582 - $814,035	12,658 New	12,658 $760,000
Q3 2019 Oct 25, 2019	SELL	$53.25 - $59.98 $771,752 - $869,290	-14,493 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$46.61 - $58.45 $33,372 - $41,850	-716 Reduced 4.71%	14,493 $0
Q1 2019 May 08, 2019	BUY	$38.66 - $51.82 $48,750 - $65,345	1,261 Added 9.04%	15,209 $767,000
Q3 2018 Nov 13, 2018	BUY	$66.65 - $83.86 $219,945 - $276,738	3,300 Added 30.99%	13,948 $967,000
Q1 2018 May 10, 2018	SELL	$52.16 - $66.86 $46,839 - $60,040	-898 Reduced 7.78%	10,648 $561,000
Q3 2017 Nov 09, 2017	BUY	$46.62 - $60.36 $538,274 - $696,916	11,546	11,546 $678,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account